BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12051111)

  • 1. Transvaginal color Doppler sonographic evaluation of the uterus in postmenopausal women on daily raloxifene therapy.
    Chittacharoen A; Theppisai U; Manonai J
    Climacteric; 2002 Jun; 5(2):156-9. PubMed ID: 12051111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study.
    de Azevedo GD; do Prado MF; Ferriani RA; dos Reis RM; Berezowski AT; Ribeiro TF; Silva E; de Oliveira Maranhão TM; Silva de Sá MF
    Maturitas; 2004 Mar; 47(3):195-200. PubMed ID: 15036489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.
    Botsis D; Christodoulakos G; Papagianni V; Lambrinoudaki I; Aravantinos L; Makrakis E; Creatsas G
    Maturitas; 2006 Feb; 53(3):362-8. PubMed ID: 16159701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women.
    Christodoulacos G; Panoulis C; Botsis D; Rizos D; Kassanos D; Creatsas G
    Maturitas; 2002 May; 42(1):77-84. PubMed ID: 12020983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):222-6. PubMed ID: 16513246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.
    Setacci C; la Marca A; Agricola E; Morgante G; Setacci F; Cappelli A; Petraglia F; De Leo V
    Am J Obstet Gynecol; 2002 Apr; 186(4):832-5. PubMed ID: 11967516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60.
    Cohen FJ; Watts S; Shah A; Akers R; Plouffe L
    Obstet Gynecol; 2000 Jan; 95(1):104-10. PubMed ID: 10636511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study.
    Post MS; van der Mooren MJ; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P
    Am J Obstet Gynecol; 2001 Sep; 185(3):557-62. PubMed ID: 11568777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of transvaginal colour Doppler sonography in evaluation of abnormal uterine bleeding.
    Dragojević S; Mitrović A; Dikić S; Canović F
    Arch Gynecol Obstet; 2005 Apr; 271(4):332-5. PubMed ID: 15029507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.
    Goldstein SR; Scheele WH; Rajagopalan SK; Wilkie JL; Walsh BW; Parsons AK
    Obstet Gynecol; 2000 Jan; 95(1):95-103. PubMed ID: 10636510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapy.
    Exacoustòs C; Lello S; Caporale E; Minghetti MC; Angelozzi D; Arduini D; Romanini C
    Fertil Steril; 1999 Mar; 71(3):536-43. PubMed ID: 10065794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal color and pulsed Doppler sonography of the endometrium: a possible role in reducing the number of dilatation and curettage procedures.
    Aleem F; Predanic M; Calame R; Moukhtar M; Pennisi J
    J Ultrasound Med; 1995 Feb; 14(2):139-45; quiz 147-8. PubMed ID: 8568960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal uterine arterial blood flow in postmenopausal women assessed by transvaginal color Doppler ultrasonography.
    Bonilla-Musoles F; Martí MC; Ballester MJ; Raga F; Osborne NG
    J Ultrasound Med; 1995 Jul; 14(7):491-4; quiz 495-6. PubMed ID: 7563295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvaginal color Doppler assessment of endometrial status in normal postmenopausal women: the effect of hormone replacement therapy.
    Bonilla-Musoles F; Ballester MJ; Martí MC; Raga F; Osborne NG
    J Ultrasound Med; 1995 Jul; 14(7):503-7. PubMed ID: 7563297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvaginal Doppler sonography: is there a role for this modality in the evaluation of women with postmenopausal bleeding?
    Wilailak S; Jirapinyo M; Theppisai U
    Maturitas; 2005 Feb; 50(2):111-6. PubMed ID: 15653008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial lesions causing uterine bleeding in postmenopausal women receiving raloxifene.
    Tsalikis T; Zepiridis L; Zafrakas M; Dinas K; Bontis J
    Maturitas; 2005 Jun; 51(2):215-8. PubMed ID: 15917163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial thickness and the Doppler sonographic parameters of the uterine arteries as discriminators of endometrial status in postmenopausal women receiving anti-hypertensive treatment.
    Ozcakir HT; Inceboz US; Utuk O; Baytur YB; Caglar H
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):396-9. PubMed ID: 15387858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.